BioengineeringJournal of Experimental MedicinePeer-reviewed
Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted Immunotherapy
R. Marone, E. Landmann, A. Devaux…·L. T. Jeker
This paper shows that epitope-engineered human hematopoietic stem cells are protected from CD123-targeted immunotherapy while maintaining functionality, offering a strategy for tumor-selective therapy.
DOI 10.1084/jem.20231235